NewsRoom Articles - Page 99 of 110 - CanadianCannabisWire

TuesdayMar 27, 2018 11:35 am

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Named to the CSE25 Index

Pivot Pharmaceuticals attains prestigious CSE25 status Recent acquisitions have extended the company’s portfolio in the cannabis space Numerous pharmaceutical and nutraceutical products in development pipeline Canadian biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) announced on March 19, 2018, that it has been named to the CSE25 Index (http://cnw.fm/g1qK7). CSE25 is a conglomerate of the 25 largest companies by market capitalization listed on the Canadian Securities Exchange. This achievement adds to Pivot Pharmaceuticals’ status as a constituent of the CSE Composite Index, which provides a distinctly different risk/return profile than the broad Canadian equity market. "With an…

FridayMar 23, 2018 11:41 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Helping Smokers Light Up Less

Poised to revolutionize smokeless tobacco Proven effective in cannabinoid delivery, undergoing testing for nicotine An enabling tech seeking third-party partnerships within the tobacco industry Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is helping smokers light up less. Using LXRP’s revolutionary technology, smokers could be able to give up smoking without giving up nicotine. With one billion smokers worldwide, companies are seeking safer delivery technologies to help wean smokers from this deadly habit. Through third-party partnerships with major tobacco industry players, LXRP is poised to revolutionize smokeless tobacco (http://cnw.fm/YP8jF). Lexaria is gaining prominence for its proprietary delivery technology. The company’s DehydraTECH™…

TuesdayMar 20, 2018 1:47 pm

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Signs Deal to Open Multiple Choom™ Branded Retail Dispensaries

Choom™ is a high-quality hand-crafted cannabis brand created for the Canadian recreational market Last month, the company opened retail opportunity to entrepreneurs and businesspeople across Canada Choom™ inked first deal, not for just a single store, but rather for an entire territory Set to be legalized in July of this year, Canada’s recreational marijuana market is estimated to exceed $8.7 billion annually. That figure doesn't include ancillary businesses such as paraphernalia, weed-related tourism, testing labs and security services. All factored in, the market potential jumps to up to $22.6 billion a year (http://cnw.fm/h2lwW). The general consensus is that the marijuana…

MondayMar 19, 2018 3:23 pm

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Seeking its Share in the Anticipated Canadian Recreational Marijuana Market

Potential Canadian marijuana market upside estimated at $22.6 billion Choom™ strategy is soil-to-shelf integration through cultivation, branding and retail marketing Company seeking phase 1 and 2 revenue growth in Vernon and Vancouver Island, British Columbia, Canada Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is focused on the recreational marijuana market in Canada and is projecting revenues from its retrofit and expansion efforts in Vernon and Vancouver Island, British Columbia, Canada. In its investor presentation of March 2018 (http://cnw.fm/pER7I), the company positioned itself to become a branded, fully integrated cannabis company in the recreational marijuana market of Canada. Its plans for…

MondayMar 19, 2018 11:54 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Details Cannabis Exportation Agreement for Sol-gel Research

Permits obtained for importation of cannabis into Australia PreveCeutical conducting research at University of Queensland for cannabinoid-based Sol-gel products Cannabis-based Sol-gel products targeted at relieving symptoms such as pain, inflammation, seizures and neurological disorders PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), a health sciences company aiming to become a preventive health sciences leader, has announced the grant of three permits from the Australian government’s Department of Health allowing for the importation of cannabis into Australia for purposes of research. The permits, which have been granted to the Pharmacy Australia Centre of Excellence (PACE) at the University of Queensland,…

FridayMar 16, 2018 2:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Aims to Generate up to 80% of Revenues from Technology Licensing

CEO Chris Bunka says in audio interview that human study of company’s proprietary TurboCBD technology will start in April outside of North America Hopes to add 6-12 more IP technology licensing contracts within year Cutting-edge research designed to attract the attention of tobacco and cannabis industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent audio interview that, although consumer products will always be important to LXRP, he estimates that up to 80 percent of its revenues could be generated through the licensing of its proprietary technology to other companies (http://cnw.fm/yT2HS). LXRP is a British…

FridayMar 16, 2018 12:53 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Readies Niche Products for Legal Cannabis Industry

Spending on legal cannabis worldwide expected to hit $57 billion by 2027 Canadian government preparing to legalize cannabis-infused edibles and beverages by mid-2019 Investments into cannabis-related companies topped $1.2 billion over first five weeks of 2018 Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis…

ThursdayMar 15, 2018 4:10 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Continues to Advance its Agenda

Owns worldwide rights for patented formulations and drug delivery technologies Develops and commercializes therapeutic pharmaceuticals and nutraceuticals Strategic agenda to become one of world’s only vertically integrated cannabis biotechs With worldwide rights for unique drug delivery platforms in place, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is rapidly building a disruptive, vertically integrated biotechnology company. Advancing this agenda, the company recently announced that it has retained Cannabis Compliance Inc. to submit an application to Health Canada for a dealer’s license on behalf of Pivot’s acquisition target, Agro-Biotech Inc. (http://cnw.fm/0K5Xn). In February, Pivot announced that its entry into a…

ThursdayMar 15, 2018 12:50 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Secures Australian Importation Permit in Support of Research into Sol-gels

Research will be conducted at PACE, a leading pharmaceutical research center in Australia PreveCeutical’s unique technology promises to be the first FDA-approved, CBD-based nose-to-brain delivery system using a Sol-gel platform Groundbreaking technology outstrips the benefits of any other delivery mechanism On March 13, 2018, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Aurora Cannabis Inc. (OTCQB: ACBFF) (TSX: ACB) (FSE: 21P) announced that they had received three permits for the importation of cannabis plant material into Australia for research purposes. The permits were granted by the Australian Government’s Department of Health, allowing shipment from Canada by Aurora Cannabis…

WednesdayMar 14, 2018 12:12 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Completes $1.5 Million Private Placement

Proceeds to be used for development of new cultivation and processing project in New Brunswick A boost to operating capital Canada plans to legalize the extraction of cannabinoids from hemp in mid-2018 Market for hemp CBD products is predicted to grow to $450 million by 2020 Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets, announced on March 7, 2018, that it had closed a non-brokered private placement, consisting of 12.5 million units at a price of $0.12 per unit, to raise…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977